Literature DB >> 14966133

Cofactor hydrogen bonding onto the protein main chain is conserved in the short chain dehydrogenase/reductase family and contributes to nicotinamide orientation.

Rong Shi1, Sheng-Xiang Lin.   

Abstract

Human estrogenic 17beta-hydroxysteroid dehydrogenase (17beta-HSD1), a member of the short chain dehydrogenase/reductase (SDR) family, is responsible for the biosynthesis of all active estrogens. The crystal structures of two C19-steroid ternary complexes (17beta-HSD1-androstanedione-NADP and 17beta-HSD1-androstenedione-NADP) reveal the critical role of Leu149 in regulating the substrate specificity and provide novel insight into the different fates of a conserved glutamate residue in the estrogen-specific proteins upon the binding of the keto and hydroxyl groups of steroids. The whole NADP molecule can be unambiguously defined in the NADP binary complex, whereas both ternary complexes show that the nicotinamide moiety of NADP cannot be located in the density maps. In both ternary complexes, the expected position of carboxamide oxygen of NADP is occupied by a water molecule, which makes a bifurcated hydrogen bond with the O3 of C19-steroid and the main chain nitrogen of Val188. These results demonstrate that the hydrogen bonding interaction between the main chain amide group and the carboxamide group of NAD(P)(H) plays an important role in anchoring the nicotinamide ring to the enzyme. This finding is substantiated by structural analyses of all 33 NAD(P)(H) complexes of different SDR proteins, because 29 structures of 33 show this interaction. This common feature reveals a general mechanism among the SDR family, providing a rational basis for inhibitor design against biologically relevant SDR targets.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14966133     DOI: 10.1074/jbc.M313156200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  The short-chain oxidoreductase Q9HYA2 from Pseudomonas aeruginosa PAO1 contains an atypical catalytic center.

Authors:  Robert Huether; Qilong Mao; William L Duax; Timothy C Umland
Journal:  Protein Sci       Date:  2010-05       Impact factor: 6.725

2.  Rational proteomics V: structure-based mutagenesis has revealed key residues responsible for substrate recognition and catalysis by the dehydrogenase and isomerase activities in human 3beta-hydroxysteroid dehydrogenase/isomerase type 1.

Authors:  Vladimir Z Pletnev; James L Thomas; Felicia L Rhaney; Lynley S Holt; Launa A Scaccia; Timothy C Umland; William L Duax
Journal:  J Steroid Biochem Mol Biol       Date:  2006-08-04       Impact factor: 4.292

3.  The functions of key residues in the inhibitor, substrate and cofactor sites of human 3beta-hydroxysteroid dehydrogenase type 1 are validated by mutagenesis.

Authors:  James L Thomas; Vance L Mack; Jingping Sun; J Ross Terrell; Kevin M Bucholtz
Journal:  J Steroid Biochem Mol Biol       Date:  2010-04-24       Impact factor: 4.292

Review 4.  Selective inhibition of human 3β-hydroxysteroid dehydrogenase type 1 as a potential treatment for breast cancer.

Authors:  James L Thomas; Kevin M Bucholtz; Balint Kacsoh
Journal:  J Steroid Biochem Mol Biol       Date:  2010-08-22       Impact factor: 4.292

5.  17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production.

Authors:  Juliette A Aka; Mausumi Mazumdar; Chang-Qing Chen; Donald Poirier; Sheng-Xiang Lin
Journal:  Mol Endocrinol       Date:  2010-02-19

Review 6.  Aromatase, estrone sulfatase, and 17β-hydroxysteroid dehydrogenase: structure-function studies and inhibitor development.

Authors:  Yanyan Hong; Shiuan Chen
Journal:  Mol Cell Endocrinol       Date:  2010-10-01       Impact factor: 4.102

7.  Structural basis for the selective inhibition of human 3beta-hydroxysteroid dehydrogenase 1 in human breast tumor MCF-7 cells.

Authors:  James L Thomas; Kevin M Bucholtz; Jingping Sun; Vance L Mack; Balint Kacsoh
Journal:  Mol Cell Endocrinol       Date:  2008-10-08       Impact factor: 4.102

8.  Structure/function of the inhibition of human 3beta-hydroxysteroid dehydrogenase type 1 and type 2 by trilostane.

Authors:  James L Thomas; Vance L Mack; Jason A Glow; Delaram Moshkelani; J Ross Terrell; Kevin M Bucholtz
Journal:  J Steroid Biochem Mol Biol       Date:  2008-05-03       Impact factor: 4.292

9.  Structure/function of human type 1 3beta-hydroxysteroid dehydrogenase: An intrasubunit disulfide bond in the Rossmann-fold domain and a Cys residue in the active site are critical for substrate and coenzyme utilization.

Authors:  James L Thomas; Robert Huether; Vance L Mack; Launa A Scaccia; Ryan C Stoner; William L Duax
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-25       Impact factor: 4.292

10.  The catalytic roles of P185 and T188 and substrate-binding loop flexibility in 3α-hydroxysteroid dehydrogenase/carbonyl reductase from Comamonas testosteroni.

Authors:  Chi-Ching Hwang; Yi-Hsun Chang; Hwei-Jen Lee; Tzu-Pin Wang; Yu-Mei Su; Hsin-Wei Chen; Po-Huang Liang
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.